Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of stocks to choose from on the S&P/ASX 200 index (ASX: XJO), but one of the best could be in this article.

That's because the team at Bell Potter believes it could offer outsized returns over the next 12 months.

Man drawing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Which ASX 200 stock?

The stock in question is gaming technology company Light & Wonder Inc (ASX: LNW).

Bell Potter highlights that the ASX 200 stock has released its results this week. And while its revenue growth was a touch softer than expected, its EBITDA beat expectations thanks to strong Gaming margins. It commented:

LNW reported +2% YoY revenue growth to $828m 3% below BPe of $852m and consensus of $847m, supported by +8% YoY growth in Gaming (-3% below BPe), -9% YoY decline in SciPlay (-7% vs. BPe) and +14% YoY growth in iGaming (+3% vs. BPe). Adj. EBITDA was $383m (+4% beat vs. BPe). Adj. NPATA of $156m was up +16% YoY (+11% beat vs. BPe). Nth. Am. 

The EBITDA beat to consensus was driven by strong Gaming margins reflecting mix shift towards Grover. Game Sales ASP and SciPlay were the drivers of the weaker than expected top line result. Restructuring costs of $6m compares to $17m in pcp, pleasing, given this line item has been consistently elevated in prior quarters.

One disappointment was its guidance, which was weaker than expected. It said:

2026 AEBITDA target of mid-to-high single digits was reiterated in mid-July 2026. Additional Gaming guidance was provided for 3Q26/2H26: Global gaming sales of 8.5-9.0k in 3Q26 (BPe 10.7k); FPD growth trending in line with CPI in 2H26 (BPe +8% YoY). Overall, these are weaker than we expected.

Big potential returns

According to the note, in response to the update, the broker has retained its buy rating on the ASX 200 stock with a trimmed price target of $183.00 (from $190.00).

Based on its current share price of $118.00, this implies potential upside of 55% for investors over the next 12 months.

To put that into context, a $10,000 investment would turn into over $15,000 if Bell Potter is on the money with its recommendation.

Commenting on its buy thesis, it said:

We retain Buy and reduce TP. We now forecast EBITDA growth of at the lower end of the company's guidance range. We see a resumption in top line growth occurring in 4Q26. We believe LNW offers compelling value at 10x EV/EBIT(A) given growth metrics.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »